Mounjaro + Free Consultation & Needles (2.5 mg)

Mounjaro (tirzepatide) is an SFDA-approved, once-weekly prescription injection indicated to improve glycemic control in adults with Type 2 Diabetes Mellitus alongside diet and exercise. Each pre-filled KwikPen contains 4 weekly doses. Dispensing requires verification of a valid prescription from a licensed healthcare professional in Saudi Arabia. Key Specifications Active Ingredient: Tirzepatide Class: Dual GIP and GLP-1 Receptor Agonist Classification: Prescription Only Medication (Rx) Mechanism & Indications Tirzepatide selectively activates native GIP and GLP-1 receptors, enhancing glucose-dependent insulin secretion, lowering glucagon, improving insulin sensitivity, and slowing gastric emptying. Indicated for adult Type 2 Diabetes Mellitus as monotherapy or with other anti-diabetic agents under clinical supervision. Dosage & Administration Route: Subcutaneous injection once weekly into the abdomen, thigh, or upper arm (rotate sites). Protocol: Initiated at 2.5 mg weekly for 4 weeks, then increased to 5 mg weekly under medical guidance. Note: Pen needles are sold separately. Safety & Storage Contraindications: Personal or family history of Medullary Thyroid Carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or severe hypersensitivity to tirzepatide. Not for Type 1 Diabetes. Common Adverse Effects: Nausea, diarrhea, decreased appetite, vomiting, constipation, and abdominal pain. Storage: Refrigerate at 2°C to 8°C. Do not freeze. Protect from light. Mandatory Disclaimers Prescription Notice: Orders are fulfilled only after verification of an authorized Saudi e-prescription or physical prescription. Don't have a prescription? No worries—a telehealth physician will contact you for clinical screening. If you are deemed medically ineligible, your order will be cancelled and 100% refunded. If eligible, your medication will be dispatched directly by our licensed partner pharmacy, HTS Company (CR No. 7021321737). Telehealth & Pharmacy Credentials: Telehealth consultation services are provided by Valeo Health Information Technologies One Person Company | MOH License No. 1400091269 | CR No. 7025162988 | Pharmacy Fulfillment Partner: HTS Company | CR No. 7021321737. Medical Disclaimer: Information is for catalog identification only and does not replace medical advice. Consult your doctor or pharmacist.